Home › Funds › Atlas Venture Life Science Advisors, LLC › QTTB
Atlas Venture Life Science Advisors, LLC position in QTTB
Q32 Bio Inc. · Health Care
Atlas Venture Life Science Advisors, LLC reported holding 2,717,106 shares of QTTB (Q32 Bio Inc.) in its Q3 2026 13F filing — a position valued at US$22.5M, representing 3.56% of its reported portfolio and ranking #6 among its reported holdings. Atlas Venture Life Science Advisors, LLC has disclosed QTTB holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Atlas Venture Life Science Advisors, LLC's QTTB position evolved
Atlas Venture Life Science Advisors, LLC first disclosed a stake in QTTB in Q1 2024 at 2,092,106 shares (US$35.6M). The position peaked in Q3 2024 at 2,092,106 shares, worth US$93.3M. Across 11 filings, Atlas Venture Life Science Advisors, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 2,717,106 shares valued at US$22.5M. Notable position changes include a 30% increase in Q2 2026 (shares fell 35% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 2.09M | $35.65M | New |
| Q2 2024 | 2.09M | $37.55M | Hold |
| Q3 2024 | 2.09M | $93.35M | Hold |
| Q4 2024 | 2.09M | $7.20M | Hold |
| Q1 2025 | 2.09M | $3.45M | Hold |
| Q2 2025 | 2.09M | $3.12M | Hold |
| Q3 2025 | 2.09M | $4.14M | Hold |
| Q4 2025 | 2.09M | $6.95M | Hold |
| Q1 2026 | 2.09M | $13.43M | Hold |
| Q2 2026 | 2.72M | $34.62M | Add |
| Q3 2026 | 2.72M | $22.47M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About QTTB and 13F data
QTTB (Q32 Bio Inc.) is a Health Care company. 57 other funds we track also report a position in QTTB — the largest reported positions include ORBIMED ADVISORS LLC (US$52.6M), Boxer Capital Management, LLC (US$40.1M), BVF INC/IL (US$29.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding QTTB
- ORBIMED ADVISORS LLC 4.13M sh · $52.59M · Q2 2026
- Boxer Capital Management, LLC 3.15M sh · $40.12M · Q2 2026
- BVF INC/IL 2.35M sh · $29.94M · Q2 2026
- Opaleye Management Inc. 931.00K sh · $11.86M · Q2 2026
- Logos Global Management LP 800.00K sh · $10.19M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 216.17K sh · $2.75M · Q2 2026
- Sanofi 244.08K sh · $2.02M · Q3 2026
- Nutshell Asset Management Ltd 98.30K sh · $812.93K · Q3 2026
- Yorkville Advisors Global, LP 10.00K sh · $82.70K · Q3 2026
More on Atlas Venture Life Science Advisors, LLC
FAQ
How long has Atlas Venture Life Science Advisors, LLC held QTTB?
Atlas Venture Life Science Advisors, LLC has disclosed QTTB holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Atlas Venture Life Science Advisors, LLC's current position in QTTB?
As of Q3 2026, Atlas Venture Life Science Advisors, LLC holds 2.72M shares of QTTB (Q32 Bio Inc.), valued at $22.47M, representing 3.56% of its reported portfolio and ranking #6.
Has Atlas Venture Life Science Advisors, LLC been buying or selling QTTB?
In the latest 13F filing (Q3 2026), Atlas Venture Life Science Advisors, LLC held unchanged its position in QTTB. The position peaked in Q3 2024 at 2.09M shares.
Which other funds hold QTTB?
Other major institutional holders of QTTB include ORBIMED ADVISORS LLC, Boxer Capital Management, LLC, BVF INC/IL, among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.